Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05993923
Other study ID # NIMAO/2022-2/CL-01
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2023
Est. completion date October 2025

Study information

Verified date August 2023
Source Centre Hospitalier Universitaire de Nimes
Contact Coralie Labarias
Phone 04.66.68.79.46
Email coralie.labarias@chu-nimes.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Health establishments encourage the development of specific care pathways for the elderly by supporting Geriatric Peri-Operative Units (GPOU). Indeed, this shared care model has shown a clear reduction in mortality and the number of re-hospitalizations in patients 6 months after their care. The multidisciplinary approach of global management of the patient in the perioperative period aims to reduce surgical stress as well as the rapid restoration of previous physical and psychic abilities. Colorectal surgery, the main treatment for stage I to III colon cancer, is a morbid surgery. Despite numerous efficacy data on improved rehabilitation after colorectal surgery, care programs are not specific to the geriatric population and geriatric assessment criteria to describe the functional status of patients are not commonly used. The study investigators wish to evaluate the impact of GPOU treatment following colorectal surgery, on the evolution of several clinical parameters such as: functional status, morbidity mortality, quality of life, and lifestyle. The study investigators hypothesize that management in the GPOU for colorectal cancer surgery in patients aged 70 and over will improve functional status at 3 months, in comparison with traditional management. The proposed intervention should also lead to an improvement in patient satisfaction with care, complications and re-hospitalizations, nutritional status, lifestyle and patient survival.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date October 2025
Est. primary completion date October 2025
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - The patient or their representative must have given their free and informed consent and signed the consent form - The patient must be a member or beneficiary of a health insurance plan - Diagnosis of proven colorectal cancer. - Patient to benefit from scheduled colorectal surgery at the University Hospital of Nîmes validated in digestive surgery SPC after oncogeriatric evaluation. - Surgical act: resection with anastomosis in one step. Exclusion Criteria: - The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Other:
GPOU
Intervention upstream of the perioperative management according to the nutritional grade. Grade 4 Nutrition patients will be hospitalized earlier, i.e. 10 to 15 days before surgery for the start of artificial nutrition. A temporary return home can be organized with the supervision of a service provider until a second admission for surgical management. Grade 2 Nutrition patients will be called 24 to 48 hours before the surgical procedure. Anticipation of discharge at admittance Early mobilization Comorbidity management Prevention of iatrogenia Management of geriatric frailties Daily medical and paramedical assessment Detailed discharge report

Locations

Country Name City State
France CHU de Nîmes Nimes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in functional status after colorectal cancer surgery between groups Instrumental Activities of Daily Living (IADL) score (score 0-8) Baseline and Month 3
Secondary Change in functional status between groups Instrumental Activities of Daily Living (IADL) score (score 0-8) Baseline and Month 6
Secondary Change in basic functional status between groups Katz index of independence in Activities of Daily Living scale (ADL) (score 0-6) Baseline, hospital discharge (an average of 10 days), Month 3, and Month 6
Secondary Change in patient motor ability between groups Time Up and Go test (Score 0-3 for each item, time in seconds) Baseline, Month 3
Secondary Patient satisfaction with care between groups EORTC SATisfaction with IN-PATient cancer care (IN-PATSAT) 32 questionnaire (Score 32-160) Hospital discharge (an average of 10 days)
Secondary Length of hospital stay between groups Days Hospital discharge (an average of 10 days)
Secondary The number of medical complications during hospitalization between groups Number of following events: diabetes decompensation, cardiorespiratory decompensation, pulmonary and urinary infections, acute renal failure, anemia. Aggravation of: confusion, pelvic exoneration disorders, fall, bedsores. Hospital discharge (an average of 10 days)
Secondary The distribution of surgical complications between groups Gravity of surgical complications according to the Clavien Dindo classification Hospital discharge (an average of 10 days)
Secondary The distribution of surgical complications between groups Gravity of surgical complications according to the Clavien Dindo classification Month 1
Secondary Destination of patients on discharge from hospital between groups Classified as: home / nursing home or institutionalization / transfer to Aftercare and Rehabilitation / transfer to another service / none (death during hospitalization). Hospital discharge (an average of 10 days)
Secondary The change in the patient's weight between groups Percent change in Kg Baseline and Month 3
Secondary Patient quality of life between groups EORTC-QLQ-C30 questionnaire score (Score 0-100) Month 3
Secondary Patient quality of life between groups EORTC-QLQ-C30 questionnaire score (Score 0-100) Month 6
Secondary Change in the patient's place of abode between groups Rate (%) of patients living at home/in nursing home/residential home Month 1, Month 3 and Month 6
Secondary Overall survival between groups. Percentage of immediate mortality (during the hospital stay) Month 1
Secondary Overall survival between groups. Percentage of immediate mortality (during the hospital stay) Month 3
Secondary Overall survival between groups. Percentage of immediate mortality (during the hospital stay) Month 6
Secondary The rate of early unscheduled re-hospitalizations or admissions to the emergency department between groups Re-hospitalization in the month following discharge from hospital: yes/no. Month 1
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A